FAB — Fusion Antibodies Share News
0.000.00%
- £7.56m
- £7.15m
- £1.14m
REG - Fusion Antibodies - Update on U.S. Patent for OptiMAL®
AnnouncementREG - AIM - AIM Notice - 12/05/2025
AnnouncementRCS - Fusion Antibodies - Investor presentation
AnnouncementREG - Fusion Antibodies - Issue of shares to non-executive directors
AnnouncementREG - Fusion Antibodies - Director/PDMR Shareholding
AnnouncementREG - Fusion Antibodies - Holding(s) in Company
AnnouncementREG - Fusion Antibodies - Trading update
AnnouncementREG - Fusion Antibodies - Total Voting Rights
AnnouncementREG - Fusion Antibodies - Approval of grant funding
AnnouncementREG - Fusion Antibodies Canaccord GenuityGrp - Holding(s) in Company
AnnouncementREG - Fusion Antibodies - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 09/04/2025
AnnouncementREG - Fusion Antibodies - Result of General Meeting
AnnouncementREG - Fusion Antibodies - Total Voting Rights
AnnouncementREG - Fusion Antibodies - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 21/03/2025
AnnouncementREG - Fusion Antibodies - Placing to raise approximately £1.17 million
AnnouncementREG - Fusion Antibodies - Contract win
AnnouncementREG - Fusion Antibodies - OptiMAL R&D Update
Announcement